Inhibition of dynamin-dependent endocytosis increases shedding of the amyloid precursor protein ectodomain and reduces generation of amyloid β protein
Inhibition of dynamin-dependent endocytosis increases shedding of the amyloid precursor protein ectodomain and reduces generation of amyloid β protein
复制标题
DOI:
--
复制
发表时间:
2005
期刊:
影响因子:
--
通讯作者:
Robyn M Carey;Brigitte A Balcz;I. López-Coviella;B. Slack
中科院分区:
文献类型:
--
作者:
Robyn M Carey;Brigitte A Balcz;I. López-Coviella;B. Slack
Background: The amyloid precursor protein (APP) is transported via the secretory pathway to the cell surface, where it may be cleaved within its ectodomain by α-secretase, or internalized within clathrin-coated vesicles. An alternative proteolytic pathway occurs within the endocytic compartment, where the sequential action of βand γ-secretases generates the amyloid β protein (Aβ). In this study, we investigated the effects of modulators of endocytosis on APP processing. Results: Human embryonic kidney cells were transfected with a dominant negative mutant of dynamin I, an important mediator of clathrin-dependent endocytosis, and APP proteolysis was analyzed. Overexpression of the mutant dynamin (dyn I K44A) resulted in increased shedding of the APP ectodomain (sAPPα), accumulation of the C-terminal α-secretase product C83, and a reduction in the release of Aβ. Levels of mature APP on the cell surface were increased in cells expressing dyn I K44A, and internalization of surface-immunolabeled APP, assessed by fluorescence microscopy, was inhibited. Dynamin is a substrate for protein kinase C (PKC), and it was hypothesized that activators of PKC, which are known to stimulate α-secretase-mediated cleavage of APP, might exert their effects by inhibiting dynamin-dependent endocytosis. However, the internalization of surface-biotinylated APP was unaffected by treatment of cells with phorbol 12myristate 13-acetate in the presence of the α-secretase inhibitor TAPI-1. Conclusion: The results indicate that APP is internalized by a dynamin-dependent process, and suggest that alterations in the activity of proteins that mediate endocytosis might lead to significant changes in Aβ production. Background The amyloid precursor protein (APP) is a single-pass transmembrane protein that gives rise to the small peptides (known as Aβ) that form amyloid deposits in the brains of patients with Alzheimer's disease (AD) [1,2]. Aβ peptides are generated by the successive cleavage of APP Published: 11 August 2005 BMC Cell Biology 2005, 6:30 doi:10.1186/1471-2121-6-30 Received: 18 March 2005 Accepted: 11 August 2005 This article is available from: http://www.biomedcentral.com/1471-2121/6/30 © 2005 Carey et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.